Market Data graphic

Life Sciences

You are here

The Life Sciences sector includes companies involved in biopharmaceuticals, medical manufacturing and distribution, and bio products.

Life sciences companies listed on CSE

Each Warrant shall entitle the warrantholder thereof, upon exercise at any time after the Issue Date and prior to the expiry time, to acquire one (1) common share upon payment of the Exercise Price of $1.00.

See the Warrant Indenture for full details.

Relay Medical is evolving an integrated Medtech incubator/accelerator platform, which develops and productizes multiple products and projects concurrently and vets strategic acquisitions, that are complimentary to current infrastructure assets and investment thesis.

Revitalist  provides patient-focused treatments for mental health and pain disorders through the operation of psychedelic-enhanced psychotherapy clinics, which guide patients through ketamine-enhanced psychotherapy.

Revitalist commenced operations in 2018 at is existing location in Knoxville Tennessee and is working on a rapid expansion in the United States. Revitalist seeks to create a global brand of psychedelic-enhanced psychotherapy clinics for ketamine-enhanced psychotherapy, psychedelic-enhanced psychotherapy, ketamine infusion therapy, vitamin infusions, and transcranial magnetic stimulation focusing on mental health and pain disorders.

Revive Therapeutics Ltd. is a life sciences company focused on the research and development of therapeutics for infectious diseases and rare disorders, and it is prioritizing drug development efforts to take advantage of several regulatory incentives awarded by the FDA such as Orphan Drug, Fast Track, Breakthrough Therapy and Rare Pediatric Disease designations.  Currently, the Company is exploring the use of Bucillamine for the potential treatment of infectious diseases, with an initial focus on severe influenza strains including COVID-19.  With its recent acquisition of Psilocin Pharma Corp., Revive is advancing the development of Psilocybin-based therapeutics in various diseases and disorders. Revive’s cannabinoid pharmaceutical portfolio focuses on rare inflammatory diseases and the Company was granted FDA orphan drug status designation for the use of Cannabidiol (CBD) to treat autoimmune hepatitis (liver disease) and to treat ischemia and reperfusion injury from organ transplantation.  For more information visit 

RISE Life Science Corp.  is currently developing and evolving medical and adult-use hemp-based formulations to create general use health and well-being products for the emerging consumer category made possible by the legalization of hemp in the United States pursuant to the Agricultural Improvement Act of 2018.  The Company launched its CBD-based sexual wellness products in June 2018.  The acquisition of Life Bloom Organics in July 2018 expanded RISE’s portfolio of CBD products from sexual health and wellness products to include general wellness and sleep products and provides access to Life Bloom’s existing channels of distribution and production in the United States and California in particular.  RISE also leverages Life Bloom’s proprietary process of nanotizing CBD for increased bioavailability (without psychoactivity) in future products created under the RISE brand umbrella.

RYAH is an IoT powered digital healthcare analytics and technology company that captures and analyzes large seed-to-consumer data to create personalized, plant-based therapies. Through the Company's proprietary, dose-measuring IoT devices and data analytics, RYAH is reshaping our understanding of plant-based medicine to positively impact cultivation methods, medical therapies, and the overall future treatment of patients for various medical conditions.

Investor note: In addition to the 201,576,818 Subordinate Voting Shares that are listed and trading, there are 292,001,900 shares reserved specifically for issuance pursuant to the conversion rights attached to the Super Voting Shares that are issued and outstanding but not listed.  The total number of equity shares assuming all are converted into the listed class would be 493,578,718.

Sativa Wellness Group Inc. is wellness company which includes a vertically integrated “seed to consumer” CBD therapeutics company that operates in the United Kingdom and the European Union. Our CBD interests include hemp production, CBD extraction, cannabinoid laboratory testing, wholesale and retail sales. Our operating facilities in Poland produce CBD isolate and distillate, and we have a production plant producing CBD and sanatizer products and a testing laboratory in the UK. We sell wholesale and white-label CBD to other businesses and own and operate a variety of our own CBD brands.

In addition we have a growing network of wellness clinics in the UK that undertake COVID testing and are developing other health screening provision.

ScreenPro provides turnkey coronavirus screening solutions to the private sector including testing, track and tracing with GoStop alerting software. ScreenPro's unique access to multiple manufacturers of high quality South Korean test kits and its strategic partnership with Canvas Labs in Vancouver and Integrated Explorations in Ontario. This platform allows ScreenPro to be a nationwide provider of a full-service testing solutions across Canada. In addition to providing test kits, ScreenPro has its own nursing professionals, and access to high quality PPE to ensure that its clients are protected in all aspects of their testing needs. GoStop's passport was developed with a privacy preserving approach that will enable individuals to use the alerting software and downloadable app with authentication certificates. The alerts can be scheduled on an on-demand, daily, weekly, or monthly basis and can be used also for vaccine scheduling.

The mission of Silo Wellness is to improve health and wellness by developing and introducing psychedelic medicine to reduce trauma and increase performance by destigmatizing the active compounds in psychedelics and innovating ease of administration and ingestion.   Silo Wellness intends to introduce new, safe, and affordable alternatives to current medicines by facilitating entry into new and emerging markets where psychedelics are legal through conducting ketamine and psilocybin wellness retreats and elsewhere by manufacturing and distributing functional mushrooms.

SLANG Worldwide Inc. is a leading cannabis centred consumer packaged goods company with a diversified portfolio of popular brands distributed across the United States. The Issuer specializes in acquiring and developing market-proven regional brands as well as launching innovative new brands to seize global market opportunities. 

Contact The Team

How can we help you?

Contact the CSE team to find out more.



Latest CSE News